{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:11:41Z","timestamp":1778760701002,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.tcm.2025.11.002","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:56:48Z","timestamp":1763186208000},"page":"232-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gene editing for inherited cardiac conditions: A new frontier in cardiology"],"prefix":"10.1016","volume":"36","author":[{"given":"Toufik","family":"Abdul-Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poulami","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abubakar","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kahan Samirkumar","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neel Ajit","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamaila","family":"Hassnain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renitha","family":"Reddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Gautham","family":"Kanagala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Ashinze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-2119","authenticated-orcid":false,"given":"Rahul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2459\/JCM.0000000000000589","article-title":"Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications","volume":"19","author":"Girolami","year":"2018","journal-title":"J Cardiovasc Med Hagerstown Md"},{"key":"10.1016\/j.tcm.2025.11.002_bib0002","unstructured":"\u201cInherited heart conditions,\u201d NHS inform. Accessed: Dec. 13, 2023. [Online]. Available: https:\/\/www.nhsinform.scot\/illnesses-and-conditions\/heart-and-blood-vessels\/conditions\/inherited-heart-conditions\/"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0003","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1161\/CIRCULATIONAHA.113.002252","article-title":"Genetic testing for inherited heart disease","volume":"128","author":"Cirino","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0004","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacbts.2018.11.004","article-title":"Therapeutic genome editing in cardiovascular diseases","volume":"4","author":"German","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"10.1016\/j.tcm.2025.11.002_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biotech10030014","article-title":"Applications of CRISPR-Cas9 as an advanced genome editing system in life sciences","volume":"10","author":"Tavakoli","year":"2021","journal-title":"BioTech"},{"issue":"12","key":"10.1016\/j.tcm.2025.11.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023754","article-title":"Genome-editing technologies: principles and applications","volume":"8","author":"Gaj","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"10.1016\/j.tcm.2025.11.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0008","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-018-0425-5","article-title":"CRISPR\/Cas9: the Jedi against the dark empire of diseases","volume":"25","author":"Khan","year":"2018","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.tcm.2025.11.002_bib0009","unstructured":"\u201cGene editing \u2013 digital media kit,\u201d National Institutes of Health (NIH). Accessed: Dec. 13, 2023. [Online]. Available: https:\/\/www.nih.gov\/news-events\/gene-editing-digital-press-kit"},{"issue":"R1","key":"10.1016\/j.tcm.2025.11.002_bib0010","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","article-title":"CRISPR\/Cas9 for genome editing: progress, implications and challenges","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.tcm.2025.11.002_bib0011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/archdischild-2016-310459","article-title":"What is CRISPR\/Cas9?","volume":"101","author":"Redman","year":"2016","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"12","key":"10.1016\/j.tcm.2025.11.002_bib0012","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCRESAHA.122.320496","article-title":"CRISPR modeling and correction of cardiovascular disease","volume":"130","author":"Liu","year":"2022","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.tcm.2025.11.002_bib0013","first-page":"249","article-title":"Gene therapy, early promises, subsequent problems, and recent breakthroughs","volume":"3","author":"Soofiyani","year":"2013","journal-title":"Adv Pharm Bull"},{"issue":"2","key":"10.1016\/j.tcm.2025.11.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101229","article-title":"Embryo and fetal gene editing: technical challenges and progress toward clinical applications","volume":"32","author":"Mattar","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.tcm.2025.11.002_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.774618","article-title":"In vivo gene therapy to the liver and nervous system: promises and challenges","volume":"8","author":"Cantore","year":"2022","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.tcm.2025.11.002_bib0016","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.tcm.2025.11.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325330","article-title":"Gene editing therapy as a therapeutic approach for cardiovascular diseases in animal models: a scoping review","volume":"20","author":"Vo","year":"2025","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0018","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1038\/s41467-023-39352-1","article-title":"Striated muscle-specific base editing enables correction of mutations causing dilated cardiomyopathy","volume":"14","author":"Grosch","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.tcm.2025.11.002_bib0019","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/jcp.30064","article-title":"CRISPR\/Cas gene therapy","volume":"236","author":"Zhang","year":"2021","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.tcm.2025.11.002_bib0020","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.2147\/IJN.S459905","article-title":"Adeno-associated virus engineering and load strategy for tropism modification, immune evasion and enhanced transgene expression","volume":"19","author":"Zhou","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.tcm.2025.11.002_bib0021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-3271-9_2","article-title":"Delivering transgenic DNA exceeding the carrying capacity of AAV vectors","volume":"1382","author":"Hirsch","year":"2016","journal-title":"Methods Mol Biol Clifton NJ"},{"issue":"5","key":"10.1016\/j.tcm.2025.11.002_bib0022","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050088","article-title":"Gene editing innovations and their applications in cardiomyopathy research","volume":"16","author":"Kyriakopoulou","year":"2023","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.tcm.2025.11.002_bib0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-981-19-5642-3_8","article-title":"Genome editing and inherited cardiac arrhythmias","volume":"1396","author":"Lalaguna","year":"2023","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"10.1016\/j.tcm.2025.11.002_bib0024","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/cells12101363","article-title":"Genome editing and cardiac arrhythmias","volume":"12","author":"Moore","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.tcm.2025.11.002_bib0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.omtn.2022.03.004","article-title":"Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice","volume":"28","author":"Karri","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.tcm.2025.11.002_bib0026","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-biochem-013118-111730","article-title":"Evaluating and enhancing target specificity of gene-editing nucleases and deaminases","volume":"88","author":"Kim","year":"2019","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.tcm.2025.11.002_bib0027","series-title":"StatPearls","article-title":"Genetics, epigenetic mechanism","author":"Al Aboud","year":"2023"},{"issue":"9","key":"10.1016\/j.tcm.2025.11.002_bib0028","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.104.519025","article-title":"Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis","volume":"112","author":"Zhu","year":"2005","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.tcm.2025.11.002_bib0029","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.tcm.2025.11.002_bib0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","article-title":"BET bromodomains mediate transcriptional pause release in heart failure","volume":"154","author":"Anand","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0031","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13148-019-0705-2","article-title":"DNA methylation modules associate with incident cardiovascular disease and cumulative risk factor exposure","volume":"11","author":"Westerman","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"7675","key":"10.1016\/j.tcm.2025.11.002_bib0032","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Consortium","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.tcm.2025.11.002_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006336","article-title":"Impairment of myocardial glutamine homeostasis induced by suppression of the amino acid carrier SLC1A5 in failing myocardium","volume":"12","author":"Kennel","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.tcm.2025.11.002_bib0034","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamacardio.2021.2704","article-title":"Blood DNA methylation and incident coronary heart disease: evidence from the strong heart study","volume":"6","author":"Navas-Acien","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13148-022-01267-x","article-title":"Integrative analysis of DNA methylation and gene expression reveals key molecular signatures in acute myocardial infarction","volume":"14","author":"Luo","year":"2022","journal-title":"Clin Epigenetics"},{"issue":"2","key":"10.1016\/j.tcm.2025.11.002_bib0036","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1073\/pnas.1523918113","article-title":"A mouse model for adult cardiac-specific gene deletion with CRISPR\/Cas9","volume":"113","author":"Carroll","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.tcm.2025.11.002_bib0037","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/msj.20151","article-title":"Genomics of cardiovascular disease","volume":"76","author":"Manace","year":"2009","journal-title":"Mt Sinai J Med N Y"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0038","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13148-021-01064-y","article-title":"DNA methylation and gene expression integration in cardiovascular disease","volume":"13","author":"Palou-M\u00e1rquez","year":"2021","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0039","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13148-021-01078-6","article-title":"DNA methylation biomarkers of myocardial infarction and cardiovascular disease","volume":"13","author":"Fern\u00e1ndez-Sanl\u00e9s","year":"2021","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.tcm.2025.11.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104281","article-title":"Histone deacetylase 6 inhibitor tubastatin a attenuates angiotensin II-induced hypertension by preventing cystathionine \u03b3-lyase protein degradation","volume":"146","author":"Chi","year":"2019","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0041","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bph.14932","article-title":"Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy","volume":"178","author":"Chelladurai","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0042","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1038\/s41598-020-61041-y","article-title":"Angiotensin II represses Npr1 expression and receptor function by recruitment of transcription factors CREB and HSF-4a and activation of HDACs","volume":"10","author":"Arise","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.tcm.2025.11.002_bib0043","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-3-319-53889-1_21","article-title":"\u201cEpigenome editing in the brain,\u201d in neuroepigenomics in aging and disease","author":"Bashtrykov","year":"2017"},{"issue":"6","key":"10.1016\/j.tcm.2025.11.002_bib0044","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nmeth.1994","article-title":"An optimized two-finger archive for ZFN-mediated gene targeting","volume":"9","author":"Gupta","year":"2012","journal-title":"Nat Methods"},{"issue":"6069","key":"10.1016\/j.tcm.2025.11.002_bib0045","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1126\/science.1215670","article-title":"Structural basis for sequence-specific recognition of DNA by TAL effectors","volume":"335","author":"Deng","year":"2012","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.tcm.2025.11.002_bib0046","first-page":"471","article-title":"CRISPR-mediated epigenome editing","volume":"89","author":"Enr\u00edquez","year":"2016","journal-title":"Yale J Biol Med"},{"issue":"6","key":"10.1016\/j.tcm.2025.11.002_bib0047","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/0897190019854962","article-title":"Gene replacement therapy: a primer for the health-system pharmacist","volume":"33","author":"Petrich","year":"2020","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.tcm.2025.11.002_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2021.618346","article-title":"The promise and the hope of gene therapy","volume":"3","author":"Papanikolaou","year":"2021","journal-title":"Front Genome Ed"},{"issue":"5","key":"10.1016\/j.tcm.2025.11.002_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050785","article-title":"Various AAV serotypes and their applications in gene therapy: an overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.tcm.2025.11.002_bib0050","doi-asserted-by":"crossref","unstructured":"A. Iqubal, M. K. Iqubal, A. Khan, J. Ali, S. Baboota, and S. E. Haque, \u201cGene therapy, a novel therapeutic tool for neurological disorders: current progress, challenges and future prospective,\u201d Curr Gene Ther, vol. 20, no. 3, pp. 184\u2013194, Accessed: Jan. 01, 2024. [Online]. Available: https:\/\/www.eurekaselect.com\/article\/108199","DOI":"10.2174\/1566523220999200716111502"},{"key":"10.1016\/j.tcm.2025.11.002_bib0051","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2052-8426-2-27","article-title":"Gene therapy for cancer: present status and future perspective","volume":"2","author":"Amer","year":"2014","journal-title":"Mol Cell Ther"},{"issue":"3","key":"10.1016\/j.tcm.2025.11.002_bib0052","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/mt.2016.5","article-title":"Current progress in therapeutic gene editing for monogenic diseases","volume":"24","author":"Prakash","year":"2016","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"9","key":"10.1016\/j.tcm.2025.11.002_bib0053","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM199008303230904","article-title":"Gene transfer into humans\u2013immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction","volume":"323","author":"Rosenberg","year":"1990","journal-title":"N Engl J Med"},{"issue":"5235","key":"10.1016\/j.tcm.2025.11.002_bib0054","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"issue":"5235","key":"10.1016\/j.tcm.2025.11.002_bib0055","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.270.5235.470","article-title":"Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients","volume":"270","author":"Bordignon","year":"1995","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.tcm.2025.11.002_bib0056","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol Genet Metab"},{"issue":"11","key":"10.1016\/j.tcm.2025.11.002_bib0057","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/mt.2010.228","article-title":"Gene therapy for SCID-X1: round 2","volume":"18","author":"Herzog","year":"2010","journal-title":"Mol Ther"},{"issue":"5644","key":"10.1016\/j.tcm.2025.11.002_bib0058","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.tcm.2025.11.002_bib0059","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis"},{"key":"10.1016\/j.tcm.2025.11.002_bib0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fonc.2019.00297","article-title":"Gene therapy leaves a vicious cycle","volume":"9","author":"Goswami","year":"2019","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.tcm.2025.11.002_bib0061","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.gt.3302243","article-title":"Insertional oncogenesis in gene therapy: how much of a risk?","volume":"11","author":"Sadelain","year":"2004","journal-title":"Gene Ther"},{"issue":"3","key":"10.1016\/j.tcm.2025.11.002_bib0062","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0063","first-page":"GE01","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J Clin Diagn Res JCDR"},{"issue":"11","key":"10.1016\/j.tcm.2025.11.002_bib0064","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1042\/BCJ20170793","article-title":"CRISPR base editors: genome editing without double-stranded breaks","volume":"475","author":"Eid","year":"2018","journal-title":"Biochem J"},{"issue":"7785","key":"10.1016\/j.tcm.2025.11.002_bib0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.tcm.2025.11.002_bib0066","doi-asserted-by":"crossref","first-page":"e3107","DOI":"10.1002\/jgm.3107","article-title":"Delivery of CRISPR\/Cas9 for therapeutic genome editing","volume":"21","author":"Xu","year":"2019","journal-title":"J Gene Med"},{"issue":"6","key":"10.1016\/j.tcm.2025.11.002_bib0067","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","article-title":"Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins","volume":"24","author":"Kim","year":"2014","journal-title":"Genome Res"},{"issue":"3","key":"10.1016\/j.tcm.2025.11.002_bib0068","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/hrt.58.3.259","article-title":"Inheritance of hypertrophic cardiomyopathy: a cross sectional and M mode echocardiographic study of 50 families","volume":"58","author":"Greaves","year":"1987","journal-title":"Br Heart J"},{"issue":"7668","key":"10.1016\/j.tcm.2025.11.002_bib0069","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23305","article-title":"Correction of a pathogenic gene mutation in human embryos","volume":"548","author":"Ma","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2025.11.002_bib0070","series-title":"GeneReviews\u00ae,","article-title":"GeneReviews\u00ae,","author":"Dietz","year":"1993"},{"issue":"11","key":"10.1016\/j.tcm.2025.11.002_bib0071","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.ymthe.2018.08.007","article-title":"Correction of the marfan syndrome pathogenic FBN1 mutation by base editing in human cells and heterozygous embryos","volume":"26","author":"Zeng","year":"2018","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"10.1016\/j.tcm.2025.11.002_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102543","article-title":"Generation of a CRISPR\/Cas9-corrected-hiPSC (NCCDFWi001-A-1) from a Marfan syndrome patient hiPSC with a heterozygous c.2613A>C variant in the fibrillin 1 (FBN1) gene","volume":"56","author":"Li","year":"2021","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.tcm.2025.11.002_bib0073","series-title":"GeneReviews\u00ae","article-title":"GeneReviews\u00ae","author":"Austin","year":"1993"},{"issue":"5","key":"10.1016\/j.tcm.2025.11.002_bib0074","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.200602-165OC","article-title":"High frequency of BMPR2 exonic deletions\/duplications in familial pulmonary arterial hypertension","volume":"174","author":"Cogan","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.tcm.2025.11.002_bib0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1183\/09031936.00187310","article-title":"Targeted gene delivery of BMPR2 attenuates pulmonary hypertension","volume":"39","author":"Reynolds","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tcm.2025.11.002_bib0076","series-title":"StatPearls","article-title":"Duchenne muscular dystrophy","author":"Venugopal","year":"2023"},{"issue":"8","key":"10.1016\/j.tcm.2025.11.002_bib0077","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.117.310996","article-title":"In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice","volume":"121","author":"El Refaey","year":"2017","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.tcm.2025.11.002_bib0078","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/eurheartj\/ehl355","article-title":"Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?","volume":"28","author":"Hofman","year":"2007","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0079","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCRESAHA.116.309283","article-title":"A precision medicine approach to the rescue of function on malignant calmodulinopathic long-QT syndrome","volume":"120","author":"Limpitikul","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2025.11.002_bib0080","first-page":"53","article-title":"The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations","volume":"3","author":"De Castro-Or\u00f3s","year":"2010","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.tcm.2025.11.002_bib0081","doi-asserted-by":"crossref","unstructured":"Zhao H, Li Y, He L, Pu W, Yu W, Li Y, et al., \u201cIn vivo AAV-CRISPR\/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia,\u201d Circulation, vol. 141, no. 1, pp. 67\u201379, Jan. 2020, doi: 10.1161\/CIRCULATIONAHA.119.042476.","DOI":"10.1161\/CIRCULATIONAHA.119.042476"},{"issue":"10","key":"10.1016\/j.tcm.2025.11.002_bib0082","doi-asserted-by":"crossref","DOI":"10.1038\/cr.2016.101","article-title":"Genome editing with CRISPR\/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome","volume":"26","author":"Xie","year":"2016","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0083","article-title":"A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods","volume":"14","author":"Gu","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.tcm.2025.11.002_bib0084","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003259","article-title":"Prediction of genotype positivity in patients with hypertrophic cardiomyopathy using machine learning","author":"Liang","year":"2021","journal-title":"Circ Genomic Precis Med"},{"key":"10.1016\/j.tcm.2025.11.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.118.313369","article-title":"In Vivo Ryr2 editing corrects catecholaminergic polymorphic ventricular tachycardia","author":"Pan","year":"2018","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0086","first-page":"12","article-title":"Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research","volume":"10","author":"Li","year":"2023","journal-title":"Mil Med Res"},{"issue":"12","key":"10.1016\/j.tcm.2025.11.002_bib0087","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"issue":"5 Pt A","key":"10.1016\/j.tcm.2025.11.002_bib0088","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.hrthm.2019.12.020","article-title":"Improving long QT syndrome diagnosis by a polynomial-based T-wave morphology characterization","volume":"17","author":"Hermans","year":"2020","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.tcm.2025.11.002_bib0089","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hrthm.2020.08.021","article-title":"Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?","volume":"18","author":"Bleijendaal","year":"2021","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.tcm.2025.11.002_bib0090","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1007\/s00330-020-07454-9","article-title":"Deep learning algorithm to improve hypertrophic cardiomyopathy mutation prediction using cardiac cine images","volume":"31","author":"Zhou","year":"2021","journal-title":"Eur Radiol"},{"issue":"17","key":"10.1016\/j.tcm.2025.11.002_bib0091","doi-asserted-by":"crossref","first-page":"i656","DOI":"10.1093\/bioinformatics\/bty554","article-title":"Off-target predictions in CRISPR-Cas9 gene editing using deep learning","volume":"34","author":"Lin","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tcm.2025.11.002_bib0092","unstructured":"\u201cGenome editing and human reproduction,\u201d The Nuffield Council on Bioethics. Accessed: Dec. 17, 2023. [Online]. Available: https:\/\/www.nuffieldbioethics.org\/publications\/genome-editing-and-human-reproduction"},{"key":"10.1016\/j.tcm.2025.11.002_bib0093","unstructured":"\u201cWhat are the ethical issues surrounding gene therapy?: MedlinePlus Genetics.\u201d Accessed: Dec. 17, 2023. [Online]. Available: https:\/\/medlineplus.gov\/genetics\/understanding\/therapy\/ethics\/"},{"issue":"7843","key":"10.1016\/j.tcm.2025.11.002_bib0094","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","article-title":"In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice","volume":"589","author":"Koblan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2025.11.002_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.760140","article-title":"Gene therapy for cardiovascular disease: basic research and clinical prospects","volume":"8","author":"Cao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.tcm.2025.11.002_bib0096","article-title":"Targeted therapy in cardiovascular disease: a precision therapy era","volume":"12","author":"Xu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.tcm.2025.11.002_bib0097","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.114.011154","article-title":"Wolff-Parkinson-White syndrome in the era of catheter ablation","author":"Pappone","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.tcm.2025.11.002_bib0098","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ihj.2023.02.001","article-title":"The success rate of radiofrequency catheter ablation in Wolff-Parkinson-White-Syndrome patients: a systematic review and meta-analysis","volume":"75","author":"Ibrahim","year":"2023","journal-title":"Indian Heart J"},{"issue":"2","key":"10.1016\/j.tcm.2025.11.002_bib0099","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.hrthm.2017.09.024","article-title":"CRISPR correction of the PRKAG2 gene mutation in the patient\u2019s induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities","volume":"15","author":"Ben Jehuda","year":"2018","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.tcm.2025.11.002_bib0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jjcc.2020.05.003","article-title":"Clinical characteristics of challenging catheter ablation procedures in patients with WPW syndrome: A 10 year single-center experience","volume":"76","author":"Fujino","year":"2020","journal-title":"J Cardiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382500146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382500146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:44:33Z","timestamp":1778759073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105017382500146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S105017382500146X"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2025.11.002","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene editing for inherited cardiac conditions: A new frontier in cardiology","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2025.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}